Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Azathioprine
Drug ID BADD_D00195
Description Azathioprine is a prodrug of 6-mercaptopurine, first synthesized in 1956 by Gertrude Elion, William Lange, and George Hitchings in an attempt to produce a derivative of 6-mercaptopurine with a better therapeutic index.[A189678,A189687,A189690] Azathioprine is used to treat inflammatory conditions like rheumatoid arthritis and as an immunosuppressant in the prevention of renal transplant rejection.[L11214] Azathiprine was granted FDA approval on 20 March 1968.[L11214]
Indications and Usage Anstey A, Lear JT: Azathioprine: clinical pharmacology and current indications in autoimmune disorders. BioDrugs. 1998 Jan;9(1):33-47.
Marketing Status Prescription; Discontinued
ATC Code L04AX01
DrugBank ID DB00993
KEGG ID D00238
MeSH ID D001379
PubChem ID 2265
TTD Drug ID D07QCE
NDC Product Code 72789-129; 51407-182; 46014-1110; 62991-2189; 12780-0300; 51927-2258; 48954-909; 51552-0779; 15308-0732; 42973-143; 68382-120; 38779-0312; 68382-119; 67877-492; 70771-1139; 65649-241; 68382-118; 67877-494; 54766-590; 68462-502; 0378-1005; 71610-124; 60219-2036; 70771-1140; 51927-0071; 65841-602; 68382-003; 71610-306; 42291-071; 60219-2037; 68084-229; 60219-1076; 70771-1141; 49452-0783; 65649-231; 67877-495; 67877-493; 66122-0009
Synonyms Azathioprine | Azothioprine | Imurel | Imuran | Immuran | Azathioprine Sodium | Sodium, Azathioprine | Azathioprine Sodium Salt | Azathioprine Sulfate
Chemical Information
Molecular Formula C9H7N7O2S
CAS Registry Number 446-86-6
SMILES CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Adverse drug reactionThiopurine S-methyltransferaseP51580Not Available15228171; 9893619; 12525681; 7818564; 7979599; 9778228; 8984938; 12429535; 7774088; 12509611; 14505127
Adverse drug reactionInosine triphosphate pyrophosphataseQ9BY32Not Available15167706; 15571265; 15973722
Adverse drug reactionThiopurine S-methyltransferaseP51580Not Available10461478; 12021625; 14566029; 8738760; 12021625
Bone marrow toxicityThiopurine S-methyltransferaseP51580Not Available15228171; 9893619; 12525681; 7818564; 7979599; 9778228; 8984938; 12429535; 7774088; 12509611; 14505127
Bone marrow toxicityCytosolic 5'-nucleotidase 1AQ9BXI3Not Available7818564; 7979599; 9778228; 8984938; 12429535; 7774088; 12509611; 14505127
Bone marrow toxicityPurine nucleoside phosphorylaseP00491T781987818564; 7979599; 9778228; 8984938; 12429535; 7774088; 12509611; 14505127
Bone marrow toxicityThiopurine S-methyltransferaseP51580Not Available10461478; 12021625; 14566029; 8738760; 12021625
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Campylobacter infection11.02.28.0010.003590%Not Available
SAPHO syndrome10.02.01.064; 23.03.10.005; 15.03.03.0130.002154%Not Available
Pulmonary sepsis22.07.01.014; 11.01.11.0140.000375%Not Available
Enterobacter infection11.02.09.0020.001436%Not Available
Focal nodular hyperplasia16.06.01.004; 09.04.01.0040.001436%Not Available
Morton's neuralgia17.02.07.0220.001436%Not Available
Small intestinal haemorrhage24.07.02.019; 07.12.03.0020.001436%
Clostridium difficile infection11.02.02.0090.009334%Not Available
Pseudopolyp08.01.05.0150.002154%Not Available
Lymphomatoid papulosis23.03.08.0110.001436%Not Available
Cell death14.11.02.005; 08.03.03.0030.001436%Not Available
Neuroendocrine carcinoma05.08.01.011; 16.24.01.0070.000749%Not Available
Gastrointestinal oedema07.11.01.0120.006462%Not Available
General physical condition abnormal13.15.01.0400.001436%Not Available
Escherichia infection11.02.10.0040.001436%Not Available
Female genital tract fistula07.11.05.004; 23.07.04.015; 21.10.05.009; 20.08.01.0070.002154%Not Available
Klebsiella infection11.02.03.0030.002872%Not Available
Papilloma viral infection11.05.07.0050.002154%Not Available
Pneumococcal infection11.02.06.0130.001436%Not Available
Small intestinal stenosis07.13.06.0080.009334%
Dysplastic naevus23.10.01.011; 16.26.01.0110.002154%Not Available
Subretinal fibrosis06.09.03.0260.000375%Not Available
Listeria sepsis11.02.11.0030.000562%Not Available
Metastatic squamous cell carcinoma16.16.01.0100.000375%Not Available
Extrapulmonary tuberculosis11.04.01.0110.012924%Not Available
Epstein-Barr virus test positive13.08.03.0160.001436%Not Available
Plasmablastic lymphoma16.35.01.004; 01.17.01.0040.000562%Not Available
Fistula of small intestine07.11.05.0100.002872%
Gastrointestinal anastomotic leak07.11.01.025; 12.02.03.0190.001436%
Human herpesvirus 8 infection11.05.02.033; 10.03.03.0080.002154%Not Available
The 26th Page    First    Pre   26 27    Next   Last    Total 27 Pages